LINEZOLID CIP linezolid 600 mg film-coated tablet blister pack

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

linezolid, Quantity: 600 mg

Доступно од:

Cipla Australia Pty Ltd

INN (Међународно име):

Linezolid

Фармацеутски облик:

Tablet, film coated

Састав:

Excipient Ingredients: magnesium stearate; maize starch; sodium starch glycollate type A; hyprolose; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000

Пут администрације:

Oral

Јединице у пакету:

10, 30

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

LINEZOLID CIP is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,LINEZOLID CIP is active against Gram-positive bacteria only.,LINEZOLID CIP has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.

Резиме производа:

Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Статус ауторизације:

Licence status A

Датум одобрења:

2017-01-24